Royan Institute
Iran
- Country
- Iran
- Ownership
- Private
- Established
- 1991-01-01
- Employees
- -
- Market Cap
- -
Intravenous Injection of Adipose Derived Mesenchymal Stem Cell for ALS
Phase 1
Completed
- Conditions
- Amyotrophic Lateral Sclerosis
- Interventions
- Biological: mesenchymal stem cells
- First Posted Date
- 2015-07-08
- Last Posted Date
- 2017-04-28
- Lead Sponsor
- Royan Institute
- Target Recruit Count
- 19
- Registration Number
- NCT02492516
- Locations
- 🇮🇷
Royan Institute, Tehran, Iran, Islamic Republic of
Molecular Evaluation of Endometrium After Endometrial Injury
Not Applicable
Completed
- Conditions
- Endometrial Injury
- Interventions
- Procedure: PIPELLE Endometrial injury
- First Posted Date
- 2015-06-24
- Last Posted Date
- 2020-09-09
- Lead Sponsor
- Royan Institute
- Target Recruit Count
- 20
- Registration Number
- NCT02480127
- Locations
- 🇮🇷
Royan Institute, Tehran, Iran, Islamic Republic of
Autologous BM-MSC Transplantation in Combination With Platelet Lysate (PL) for Nonunion Treatment
Phase 2
- Conditions
- Bone Fracture
- Interventions
- Other: Percutaneous injection
- First Posted Date
- 2015-05-20
- Last Posted Date
- 2015-10-30
- Lead Sponsor
- Royan Institute
- Target Recruit Count
- 60
- Registration Number
- NCT02448849
- Locations
- 🇮🇷
Royan Institute, Tehran, Iran, Islamic Republic of
Allogenic AD-MSC Transplantation in Idiopathic Nephrotic Syndrome (Focal Segmental Glomerulosclerosis)
Phase 1
- Conditions
- Focal Segmental Glomerulosclerosis
- Interventions
- Biological: Intravenous injection
- First Posted Date
- 2015-03-09
- Last Posted Date
- 2015-12-04
- Lead Sponsor
- Royan Institute
- Target Recruit Count
- 5
- Registration Number
- NCT02382874
- Locations
- 🇮🇷
Royan Institute, Tehran, Iran, Islamic Republic of
Intrauterine Injection of Human Chorionic Gonadotropin Injection (hCG) Before Frozen Embryo Transfer on Cycle Outcomes
Phase 3
Completed
- Conditions
- Infertility
- Interventions
- Drug: PlaceboDrug: intrauterine injection of uhCGOther: control
- First Posted Date
- 2015-02-04
- Last Posted Date
- 2018-12-28
- Lead Sponsor
- Royan Institute
- Target Recruit Count
- 180
- Registration Number
- NCT02355925
- Locations
- 🇮🇷
Royan Institute, Tehran, Iran, Islamic Republic of
Frozen Embryo Transfer in Natural and Hormonal Replacement Cycles
Phase 3
- Conditions
- Infertility
- Interventions
- Biological: frozen Embryo transferDrug: 10,000U hCG injectionDrug: administration of 6 mg Estradiol valerate
- First Posted Date
- 2014-09-29
- Last Posted Date
- 2015-05-06
- Lead Sponsor
- Royan Institute
- Target Recruit Count
- 460
- Registration Number
- NCT02251925
- Locations
- 🇮🇷
Royan Institute, Tehran, Iran, Islamic Republic of
Intramuscular Transplantation of Muscle Derived Stem Cell and Adipose Derived Mesenchymal Stem Cells in Patients With Facioscapulohumeral Dystrophy (FSHD)
Phase 1
- Conditions
- Dystrophy
- Interventions
- Biological: Intramuscular injection
- First Posted Date
- 2014-08-05
- Last Posted Date
- 2017-04-27
- Lead Sponsor
- Royan Institute
- Target Recruit Count
- 21
- Registration Number
- NCT02208713
- Locations
- 🇮🇷
Royan Institute, Tehran, Iran, Islamic Republic of
Autologous Bone Marrow Derived Mesenchymal Stromal Cells (BM-MSCs) in Patients With Chronic Kidney Disease (CKD)
Phase 1
Completed
- Conditions
- Chronic Kidney Disease
- Interventions
- Biological: Intravenous injection
- First Posted Date
- 2014-07-21
- Last Posted Date
- 2016-01-05
- Lead Sponsor
- Royan Institute
- Target Recruit Count
- 7
- Registration Number
- NCT02195323
- Locations
- 🇮🇷
Royan Institute, Tehran, Iran, Islamic Republic of
Mesenchymal Stem Cells Transplantation in Patients With Chronic Renal Failure Due to Polycystic Kidney Disease
Phase 1
Completed
- Conditions
- Polycystic Kidney DiseaseChronic Renal Failure
- Interventions
- Biological: Intravenous injection autologous mesenchymal stem cells
- First Posted Date
- 2014-06-18
- Last Posted Date
- 2016-01-05
- Lead Sponsor
- Royan Institute
- Target Recruit Count
- 6
- Registration Number
- NCT02166489
- Locations
- 🇮🇷
Royan Institute, Tehran, Iran, Islamic Republic of
Paraurethral Transplantation of Autologous Muscle Derived Stem Cells for Treatment of Stress Incontinency
Phase 2
Completed
- Conditions
- Stress Urine Incontinency
- Interventions
- Biological: paraurethral injection
- First Posted Date
- 2014-06-05
- Last Posted Date
- 2015-12-04
- Lead Sponsor
- Royan Institute
- Target Recruit Count
- 20
- Registration Number
- NCT02156934
- Locations
- 🇮🇷
Royan Institute, Tehran, Iran, Islamic Republic of
© Copyright 2025. All Rights Reserved by MedPath